Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
1991-9-4
pubmed:abstractText
Effective stimulation of CD4+ T cells in an immune response depends on activation signals transduced via not only the CD3-T-cell receptor (TCR) complex but also those generated by accessory cell-surface proteins, including some that mediate adhesion between T cells and antigen-presenting cells (APC). Three members of the Ig superfamily, CD54 [intercellular cell adhesion molecule 1 (ICAM-1)], CD58 [lymphocyte function-associated antigen 3 (LFA-3)], and B7, expressed on the surface of APC, have been shown to mediate both adhesion and signaling during T cell-APC interactions. Recently another member of the Ig superfamily, [vascular cell adhesion molecule 1 (VCAM-1; INCAM110)], has been identified. VCAM-1 mediates adhesion between endothelial cells and activated lymphocytes and certain tumor cells. Here, using a soluble VCAM-1 fusion protein with receptor globulin (Rg), we examined the role of VCAM-1 in T-cell activation. We observed that CD4+ T cells, which are inefficiently stimulated by immobilized anti-TCR-1 or anti-CD3 monoclonal antibody (mAb) alone, can be induced to proliferate when exposed to immobilized VCAM-1-Rg in conjunction with either immobilized anti-TCR-1 or immobilized anti-CD3 mAb. The costimulatory effects of VCAM-1-Rg on CD4+T cells is inhibited by mAb to either the CD29 (integrin beta 1)-CD49d [very late activation antigen 4 alpha (VLA-4 alpha)] complex on the surface of CD4+ T cells or to VCAM-1. Stimulation of CD4+ T cells with immobilized VCAM-1-Rg and anti-TCR or -CD3 mAb results in the synthesis of both interleukin 2 (IL-2) receptors and IL-2. In addition, anti-CD25 (anti-IL-2 receptor a) mAb significantly inhibited the VCAM-1-Rg/anti-TCR or -CD3 mAb-driven activation of CD4+ T cells, indicating that endogenously produced IL-2 is in part responsible for the observed T-cell proliferation. Collectively, these results suggest that VCAM-1 can play an important costimulatory role during the activation of CD4+ T cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1689216, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1691264, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1694723, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1695644, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1695646, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1697696, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1847722, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1972721, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1974032, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-1976737, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2139716, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2162180, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2188667, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2190954, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2211998, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2477485, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2527858, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2551146, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2570801, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-2688898, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-3028640, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-307029, http://linkedlifedata.com/resource/pubmed/commentcorrection/1713678-3109455
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6403-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:1713678-Antibodies, Monoclonal, pubmed-meshheading:1713678-Antigens, CD4, pubmed-meshheading:1713678-Base Sequence, pubmed-meshheading:1713678-Cell Adhesion Molecules, pubmed-meshheading:1713678-Cloning, Molecular, pubmed-meshheading:1713678-Humans, pubmed-meshheading:1713678-Kinetics, pubmed-meshheading:1713678-Lymphocyte Activation, pubmed-meshheading:1713678-Molecular Sequence Data, pubmed-meshheading:1713678-Oligonucleotide Probes, pubmed-meshheading:1713678-Polymerase Chain Reaction, pubmed-meshheading:1713678-Receptors, Antigen, T-Cell, pubmed-meshheading:1713678-Receptors, Interleukin-2, pubmed-meshheading:1713678-Recombinant Proteins, pubmed-meshheading:1713678-T-Lymphocyte Subsets, pubmed-meshheading:1713678-T-Lymphocytes, pubmed-meshheading:1713678-Vascular Cell Adhesion Molecule-1
pubmed:year
1991
pubmed:articleTitle
Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes.
pubmed:affiliation
Oncogen Division, Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.
pubmed:publicationType
Journal Article, In Vitro